Pricing Log in Create free account

Kiora Pharmaceuticals, Inc. (KPRX) vs Tempest Therapeutics, Inc. (TPST)

Kiora Pharmaceuticals, Inc. and Tempest Therapeutics, Inc. are both Biotechnology companies. Kiora Pharmaceuticals, Inc. and Tempest Therapeutics, Inc. are of similar size ($10.7M and $10.7M). Kiora Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 983.7% against −53.0%. Across the 12 metrics below, Kiora Pharmaceuticals, Inc. leads on 9 and Tempest Therapeutics, Inc. on 3.

Valuation

Metric KPRX TPST Biotechnology median
P/E n/m n/m 8.50
P/S 0.79 29.13 9.71
P/B 0.88 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.15 n/m 0.64
EV/Sales (0.10) 33.65 9.21
Earnings yield (103.07%) (690.32%) (33.15%)
Free cash flow yield (58.10%) (224.23%) (25.50%)

Profitability

Metric KPRX TPST Biotechnology median
Gross margin 85.06% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (56.36%) (931.14%) (56.36%)
Return on assets (39.43%) (237.25%) (48.04%)
Return on invested capital (44,053.91%) 0.00% 0.00%

Growth

Metric KPRX TPST Biotechnology median
Revenue growth (TTM) 983.73% (52.98%) 6.02%
EPS growth (last fiscal year) (403.45%) 67.55% 30.26%
Revenue growth, 5-year CAGR 88.72% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric KPRX TPST Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 8.97 0.38 4.72
Net debt to EBITDA 1.33 0.29 0.96

Dividend

Metric KPRX TPST Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric KPRX TPST Biotechnology median
Market cap 10.66m 10.73m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack